Accessibility StatementSkip Navigation - GLIX1 restores TET2 activity in cancer, resulting in double stranded DNA breaks in cancer cells only - - FDAÂ IND clearance received for Phase 1/2a study, expected to initiate in Q1 2026 - -Â Glioblastoma market opportunity estimated to be in excess of $3.8 billion annually across the US and EU5 by 2030 - -Â BioLineRx affirms its cash runway into the first half of 2027 - Urgent Unmet Need and Significant Commercial Opportunity in Glioblastoma GBM is the most common a ...

Accessibility StatementSkip Navigation Western Midstream (PRNewsfoto/Western Midstream Partners, LP) Aris Water Solutions, Inc. HOUSTON, Sept. 29, 2025 /PRNewswire/ --Â Western Midstream Partners, LP (NYSE: WES) ("WES") and Aris Water Solutions, Inc. (NYSE: ARIS) ("Aris") jointly announced today that, in connection with WES's pending acquisition of Aris (the "Transaction"), the deadline for Aris securityholders to elect the form of merger consideration they wish to receive in the Transaction, as described i ...

Accessibility StatementSkip Navigation "As the leading competitive generator in Texas, customers from residential to commercial and industrial are turning to Vistra to help them meet their energy needs," said Jim Burke, president and CEO of Vistra. "We recognize that energy is critical to powering this economic opportunity, and we expect Texas will play an outsized role. Based on our ongoing conversations with customers, we are affirming our multi-year plan to add more than 2,000 MW of new capacity in ERCOT ...

Accessibility StatementSkip Navigation Stock Market Symbols GIB.A (TSX) GIB (NYSE) cgi.com/newsroom Delivering seamless connectivity between banks and corporates through ecosystem collaboration "CGI is dedicated to advancing the digitization of trade finance by acting as the bridge between institutions and innovative fintech networks, ensuring the industry, and our clients, can scale confidently," said Neil Sadler, Senior Vice-President, Banking and Financial Markets, CGI in the UK. "Banks are at the heart ...

Accessibility StatementSkip Navigation EVANSVILLE, Ind. and PROVIDENCE, R.I., Sept. 29, 2025 /PRNewswire/ --Â Escalade, Inc. (NASDAQ:Â ESCA), a leader in archery, sporting goods and indoor/outdoor recreation equipment, today announced the acquisition of the Gold Tip business from Revelyst Inc., a collective of world-class maker brands that design and manufacture sports technology and outdoor gear. Founded in 1989, Gold Tip is a leading manufacturer of products for target archery and bow and crossbow hunting ...

Accessibility StatementSkip Navigation All Bitcoin to Be Retained in Corporate Treasury as Part of Long-Term Digital Asset Strategy LAS VEGAS, Sept. 29, 2025 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company ("Hyperscale Data" or the "Company"), today announced that it is upgrading its fleet of Bitcoin miners as part of a broader strategic initiative to optimize its Michigan data center (the "Michigan Facility") operations. The Company has made the strategic decision ...

Accessibility StatementSkip Navigation Hanmi and HHP will grant Gilead an exclusive license to Encequidar and provide access to drug supply. Orascoveryâ"¢ is an innovative oral drug delivery proprietary platform owned by Hanmi that enables the conversion of injectable medicines into oral formulations. Encequidar is a P-gp inhibitor that was discovered through Hanmi's Orascoveryâ"¢ platform and originally developed by Hanmi. Under this agreement, Hanmi and HHP will grant Gilead exclusive global rights to Enc ...

Accessibility StatementSkip Navigation Accelerating AI Innovation toFind New Growth Driver BEIJING, Sept. 29, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial services in Asia, announced increasing growth momentum in its internet insurance business. The Company has continued to strategically evolve and expand this business by leveraging innovative artificial intelligence (AI) technology to precisely ...

公司荣誉与行业认可 - 公司荣获Frost & Sullivan 2025年亚太地区技术创新领导力奖 表彰其在集成智能药物发现行业的卓越成就 [2] - 该奖项是Frost & Sullivan最高荣誉 认可公司在临床前研发中推动变革性效率的突出表现 [2] - 公司在战略制定与执行方面表现突出 在严格的基准测试中脱颖而出 [3] 技术创新与平台优势 - 公司通过多模态人工智能与广泛湿实验室验证结合 建立行业最多功能发现平台之一 [4] - AI驱动药物发现平台包含V-Scepter、V-Orb和V-Mantle三大模块 结合预测建模、物理模拟和生成式AI [5] - V-Scepter提供生物系统自动化参数化功能 支持小分子和肽类包括非经典氨基酸 [9] - V-Orb包含物理驱动建模 专有FEP计算套件优化非共价/共价结合剂及生物制剂 [9] - V-Mantle具备生成式AI能力 包括蛋白质大语言模型和抗体工程工作流 [9] 平台性能与客户成果 - 平台支持超过50家全球客户的150多个项目 实现发现速度提升30-50%和成本降低高达70% [6] - 平台支持多种治疗模式 包括小分子、抗体以及PROTACs、分子胶和RNA靶向化合物等新兴疗法 [4] - 平台在广泛靶点包括挑战性靶点上保持持续高成功率 [6] 商业模式与服务范围 - 公司提供从早期基于结构的药物研发到商业化生产的一站式服务 [10] - 技术平台涵盖X射线结晶、冷冻电镜、DEL、ASMS、SPR、HDX、AIDD/CADD等前沿技术 [10] - 通过子公司Langhua Pharma提供从临床前到商业化生产的CMC一站式服务 [10] - 采用服务换股权模式支持高潜力初创公司解决未满足医疗需求 [10] 战略愿景与行业影响 - 公司致力于构建真正整合AI驱动药物发现与基于结构药物发现的平台 [8] - 通过AI驱动建模和基于结构的药物发现加速全球客户决策支持 [7] - 公司投资无缝实验室闭环系统 支持全球客户的首创项目 [7]

NEW YORK , Sept. 29, 2025 /PRNewswire/ --Â Milbank LLP has been analyzing recent developments implicating unsecured creditors of Braskem S.A. ...